$0.07 EPS Expected for athenahealth, Inc (ATHN) This Quarter
Analysts expect athenahealth, Inc (NASDAQ:ATHN) to report $0.07 earnings per share for the current fiscal quarter, according to Zacks. Twelve analysts have provided estimates for athenahealth’s earnings. The highest EPS estimate is $0.11 and the lowest is $0.03. athenahealth reported earnings per share of $0.06 in the same quarter last year, which would suggest a positive year-over-year growth rate of 16.7%. The business is scheduled to report its next earnings report on Thursday, July 20th.
On average, analysts expect that athenahealth will report full year earnings of $0.84 per share for the current fiscal year, with EPS estimates ranging from $0.75 to $0.89. For the next fiscal year, analysts expect that the company will report earnings of $1.09 per share, with EPS estimates ranging from $0.90 to $1.25. Zacks Investment Research’s earnings per share calculations are an average based on a survey of sell-side research analysts that that provide coverage for athenahealth.
athenahealth (NASDAQ:ATHN) last announced its earnings results on Thursday, April 27th. The health services provider reported $0.10 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $0.11 by $0.01. athenahealth had a net margin of 1.94% and a return on equity of 6.41%. The firm had revenue of $285.40 million for the quarter, compared to the consensus estimate of $296.49 million. During the same period in the prior year, the business earned $0.34 EPS. The company’s quarterly revenue was up 11.4% compared to the same quarter last year.
ATHN has been the subject of a number of recent research reports. Dougherty & Co dropped their target price on athenahealth from $150.00 to $143.00 and set a “buy” rating for the company in a research report on Monday, February 6th. Oppenheimer Holdings Inc. set a $142.00 target price on athenahealth and gave the stock a “buy” rating in a research report on Saturday, February 4th. Robert W. Baird set a $155.00 target price on athenahealth and gave the stock a “buy” rating in a research report on Friday, February 3rd. KeyCorp set a $140.00 target price on athenahealth and gave the stock a “buy” rating in a research report on Monday, February 6th. Finally, Berenberg Bank initiated coverage on athenahealth in a research report on Tuesday, February 7th. They set a “buy” rating and a $143.00 target price for the company. One analyst has rated the stock with a sell rating, nine have issued a hold rating and twelve have issued a buy rating to the company’s stock. The stock presently has a consensus rating of “Buy” and a consensus price target of $134.00.
In other athenahealth news, SVP Bradford Kyle Armbrester sold 2,431 shares of the business’s stock in a transaction dated Thursday, May 18th. The stock was sold at an average price of $130.00, for a total value of $316,030.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Jonathan Bush sold 4,000 shares of the business’s stock in a transaction dated Thursday, May 18th. The shares were sold at an average price of $125.85, for a total value of $503,400.00. Following the completion of the transaction, the chief executive officer now directly owns 319,807 shares of the company’s stock, valued at $40,247,710.95. The disclosure for this sale can be found here. Over the last three months, insiders sold 16,331 shares of company stock valued at $2,020,274. Insiders own 3.04% of the company’s stock.
A number of hedge funds and other institutional investors have recently bought and sold shares of the stock. BlackRock Inc. boosted its position in athenahealth by 30,642.6% in the first quarter. BlackRock Inc. now owns 1,599,847 shares of the health services provider’s stock worth $180,286,000 after buying an additional 1,594,643 shares during the last quarter. Janus Capital Management LLC boosted its position in athenahealth by 18.1% in the fourth quarter. Janus Capital Management LLC now owns 5,738,978 shares of the health services provider’s stock valued at $603,596,000 after buying an additional 878,970 shares in the last quarter. Morgan Stanley boosted its position in athenahealth by 9.7% in the first quarter. Morgan Stanley now owns 4,514,305 shares of the health services provider’s stock valued at $508,717,000 after buying an additional 397,837 shares in the last quarter. Camber Capital Management LLC purchased a new position in athenahealth during the fourth quarter valued at $31,551,000. Finally, Arrowpoint Asset Management LLC boosted its position in athenahealth by 149.1% in the fourth quarter. Arrowpoint Asset Management LLC now owns 454,069 shares of the health services provider’s stock valued at $47,754,000 after buying an additional 271,759 shares in the last quarter.
Shares of athenahealth (NASDAQ:ATHN) traded up 2.27% on Wednesday, reaching $135.06. The company had a trading volume of 452,340 shares. The firm has a market cap of $5.38 billion, a P/E ratio of 265.87 and a beta of 1.77. athenahealth has a one year low of $90.11 and a one year high of $142.40. The company has a 50-day moving average price of $113.06 and a 200-day moving average price of $111.55.
athenahealth Company Profile
athenahealth, Inc provides network-based medical record, revenue cycle, patient engagement, care coordination and population health services. The Company also offers Epocrates and other point-of-care mobile applications. The Company delivers majority of its service offerings through a single instance of cloud-based software, athenaNet.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for athenahealth Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for athenahealth Inc and related companies with MarketBeat.com's FREE daily email newsletter.